BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22654538)

  • 1. Treatment of keratoacanthoma: Is intralesional methotrexate an option?
    Patel NP; Cervino AL
    Can J Plast Surg; 2011; 19(2):e15-8. PubMed ID: 22654538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate.
    Moss M; Weber E; Hoverson K; Montemarano AD
    Dermatol Surg; 2019 Jul; 45(7):877-883. PubMed ID: 30608293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional methotrexate for the treatment of keratoacanthoma: retrospective study and review of the korean literature.
    Yoo MG; Kim IH
    Ann Dermatol; 2014 Apr; 26(2):172-6. PubMed ID: 24882970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
    Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
    J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Intralesional Methotrexate in the Treatment of a Large Keratoacanthoma of the Dorsal Hand in a 99-Year-Old Woman.
    Della Valle V; Milani M
    Case Rep Dermatol; 2018; 10(3):247-250. PubMed ID: 30519171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.
    Nofal A; Alakad R; Wahid R; Hoseiny HAM
    Arch Dermatol Res; 2024 Jun; 316(7):400. PubMed ID: 38878177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative Efficacy of Nonoperative Treatment of Keratoacanthomas.
    Seger EW; Tarantino IS; Neill BC; Wang T
    J Cutan Med Surg; 2020; 24(1):41-46. PubMed ID: 31591899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series.
    Aubut N; Alain J; Claveau J
    J Cutan Med Surg; 2012; 16(3):212-7. PubMed ID: 22713449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solitary Large Keratoacanthomas of the Head and Neck: An Observational Study.
    Rossi AM; Park B; Qi B; Lee EH; Busam KJ; Nehal KS
    Dermatol Surg; 2017 Jun; 43(6):810-816. PubMed ID: 28296794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional Methotrexate for the Treatment of Advanced Keratinocytic Tumors: A Multi-Center Retrospective Study.
    Gualdi G; Caravello S; Frasci F; Giuliani F; Moro R; Fargnoli MC; Ciciarelli V; Argenziano G; Giorgio CM; Requena C; Nagore E; Sanmartín O; Martorell A; Fantini F; Calzavara-Pinton P; Amerio P
    Dermatol Ther (Heidelb); 2020 Aug; 10(4):769-777. PubMed ID: 32535811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate.
    Veerula VL; Ezra N; Aouthmany M; Graham TA; Wolverton SE; Somani AK
    Cutis; 2016 Dec; 98(6):E12-E15. PubMed ID: 28099546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
    Doerfler L; Hanke CW
    J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional therapy for the treatment of keratoacanthoma.
    Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
    Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological findings after intralesional methotrexate treatment in cutaneous squamous cell carcinoma.
    Bergón-Sendín M; Parra-Blanco V; Pulido-Pérez A; Nieto-Benito LM; Rosell-Díaz ÁM; Suárez-Fernández R
    Dermatol Ther; 2020 Nov; 33(6):e14377. PubMed ID: 33030310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience.
    Scalvenzi M; Patrì A; Costa C; Megna M; Napolitano M; Fabbrocini G; Balato N
    Dermatol Ther (Heidelb); 2019 Jun; 9(2):369-372. PubMed ID: 30790234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of keratoacanthoma with intralesional fluorouracil.
    Goette DK; Odom RB
    J Am Acad Dermatol; 1980 Mar; 2(3):212-6. PubMed ID: 7364978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
    Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
    Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional methotrexate in dermatology: Diverse indications and practical considerations.
    Searle T; Ali FR; Al-Niaimi F
    Dermatol Ther; 2021 Jan; 34(1):e14404. PubMed ID: 33044042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional methotrexate as non-surgical therapy for giant keratoacanthoma on the nose.
    Sayan A; Taibjee S; Ilankovan V
    Br J Oral Maxillofac Surg; 2024 Feb; 62(2):203-205. PubMed ID: 38267280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of keratoacanthomas with intralesional methotrexate.
    Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.